Essity AB (publ) (STO: ESSITY.A)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 217.96B |
| Revenue (ttm) | 145.18B |
| Net Income (ttm) | 19.11B |
| Shares Out | n/a |
| EPS (ttm) | 27.21 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Mar 22, 2024 |
| Volume | 3,513 |
| Open | 308.00 |
| Previous Close | 309.00 |
| Day's Range | 307.50 - 312.00 |
| 52-Week Range | 228.50 - 312.00 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 24, 2024 |
About Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through Health & Medical, Consumer Goods, and Professional Hygiene segments. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, wet wipes, wash gloves, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to fa... [Read more]
Financial Performance
In 2023, Essity AB's revenue was 147.15 billion, an increase of 12.05% compared to the previous year's 131.32 billion. Earnings were 9.55 billion, an increase of 71.62%.
Financial StatementsNews
Essity: Interim Report, Quarter 2, 2024
STOCKHOLM , July 18, 2024 /PRNewswire/ -- Quarter 2, 2024 - Strong earnings and good underlying growth Net sales decreased 1.2% to SEK 36,617m (37,078) Organic growth amounted to -0.9%, of which volu...
Invitation to presentation of Essity's interim report for quarter 2, 2024
STOCKHOLM , June 18, 2024 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 2, 2024 on July 18, at approximately 07:00 CET. President and CEO Magnus Gro...
Essity's Interim Report, Quarter 1, 2024
STOCKHOLM , April 25, 2024 /PRNewswire/ -- Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352) Organic growth amounted to -4.0%, of which volume...
Invitation to presentation of Essity's interim report for the first quarter 2024
STOCKHOLM , March 25, 2024 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for the first quarter of 2024 on April 25 at approximately 07:00 CET. President and CEO...
Regulatory approvals granted for the public offer in Essity's subsidiary Vinda
STOCKHOLM , March 4, 2024 /PRNewswire/ -- Today, Isola Castle Ltd, together with Vinda International Holdings Limited (Vinda), announced that the required regulatory approvals for the public offer for...
Essity: Interim Report Quarter 3 2023
STOCKHOLM , Oct. 26, 2023 /PRNewswire/ -- JANUARY 1 – SEPTEMBER 30, 2023 (compared with the corresponding period a year ago) Net sales increased 16.1% to SEK 130,372m (112,339). Sales growth, includin...
Invitation to presentation of Essity's Interim Report for the third quarter 2023
STOCKHOLM , Sept. 26, 2023 /PRNewswire/ -- Essity's Interim Report for the third quarter 2023 will be published on October 26, at approximately 07:00 CET.
Invitation to presentation of Essity's Interim Report for the first quarter 2023
STOCKHOLM , March 27, 2023 /PRNewswire/ -- Essity's Interim Report for the first quarter 2023 will be published on April 27, at approximately 7:00 CET. In conjunction with publication, a telephone and...
Essity recognized as a European diversity leader by Financial Times
STOCKHOLM , Nov. 18, 2022 /PRNewswire/ -- The hygiene and health company Essity has - for the second consecutive year - been designated a Diversity Leader by the UK business daily Financial Times. The...